CIK 0001228627
- Non-accelerated filer
- Smaller reporting company
Opus Genetics, Inc.
Sign in to watch- Ticker
- IRD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 113516358
- Phone
- +1 984-884-6030
- Business address
- 8 DAVIS DRIVE, SUITE 220, DURHAM, NC, 27713
- Former names
- Ocuphire Pharma, Inc., REXAHN PHARMACEUTICALS, INC., CORPORATE ROAD SHOW DOT COM INC, FERRARO FRANK
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $3,211,769
- in 7 filings, $50K under 10b5-1 plans
Net −$3,211,769. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Foundation Fighting Blindness Retinal Degeneration Fund −$2.8M Director sold 15% of stake
- Gagnon Robert E. −$177K Chief Financial Officer sold 7% of stake
- Magrath George −$145K Chief Executive Officer sold 2% of stake
- YERXA BENJAMIN R −$117K President sold 5% of stake
- SCHACHLE JOSEPH K −$17K Chief Operating Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-03-13 | Hoffmann Bernhard SVP of Corp. Dev. | Grant or award | +29,500 | 185,446 | ||
| 2025-03-13 | Hoffmann Bernhard SVP of Corp. Dev. | Grant or award · Employee Stock Option (right to buy) | +29,500 | 29,500 | ||
| 2025-02-04 | Hoffmann Bernhard SVP of Corp. Dev. | Shares withheld for taxes | −6,751 | $1.14 | $8K | 155,946 |
| 2024-01-18 | Hoffmann Bernhard SVP of Corp. Dev. | Grant or award | +20,000 | 162,697 | ||
| 2024-01-18 | Hoffmann Bernhard SVP of Corp. Dev. | Grant or award · Employee Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2024-01-10 | Hoffmann Bernhard SVP of Corp. Dev. | Shares withheld for taxes | −4,031 | $3.27 | $13K | 142,697 |
| 2023-01-10 | Hoffmann Bernhard SVP of Corp. Dev. & Ops & Sec. | Grant or award | +46,608 | 146,728 | ||
| 2023-01-10 | Hoffmann Bernhard SVP of Corp. Dev. & Ops & Sec. | Grant or award · Employee Stock Option (right to buy) | +69,912 | 69,912 | ||
| 2022-01-28 | Hoffmann Bernhard VP of Corp. Dev. & Ops & Sec. | Grant or award · Employee Stock Option (right to buy) | +42,500 | 42,500 | ||
| 2020-11-11 | Hoffmann Bernhard VP of Corp. Dev. & Ops & Sec. | Grant or award · Employee Stock Option (right to buy) | +20,000 | 20,000 | ||
| 2020-11-05 | Hoffmann Bernhard VP of Corp. Dev. and Secretary | Grant or award | +100,120 | 100,120 | ||
| 2020-11-05 | Hoffmann Bernhard VP of Corp. Dev. and Secretary | Grant or award · Employee Stock Option (right to buy) | +42,867 | 42,867 | ||
| 2020-11-05 | Hoffmann Bernhard VP of Corp. Dev. and Secretary | Grant or award · Employee Stock Option (right to buy) | +30,110 | 30,110 | ||
| 2020-11-05 | Hoffmann Bernhard VP of Corp. Dev. and Secretary | Grant or award · Employee Stock Option (right to buy) | +4,226 | 4,226 |
Page 1 of 1 · 14 trades